What Wavelet Medical does

Wavelet Medical is a New Haven-based, Yale University spin-out developing the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform. The company's core product is a hardware-and-software system that places sensors on the mother's abdomen and applies proprietary machine learning algorithms to reconstruct fetal brain activity in real time, enabling clinicians to detect neurological distress directly rather than relying on indirect fetal heart rate monitoring — a method that the company states is indeterminate in up to 85% of births. The intended use cases span detection of preventable brain injuries at birth and reduction of unnecessary Caesarean sections driven by inconclusive monitoring data.

The technology stack is built around proprietary signal-reconstruction ML models trained on EEG data, with claimed capabilities in real-time anomaly detection and predictive analytics for fetal neurological outcomes. As of April 2026, the platform is being validated clinically at three sites — Yale University, LA General Hospital/USC, and Yonsei University Health System in South Korea — with approximately 300 patients enrolled. The company has secured $7 million in seed funding led by Aegis Ventures (April 2026) under a co-creation partnership intended to accelerate global commercial expansion, and has stated a near-term goal of deploying at five to seven U.S. hospitals across urban and rural settings.

Wavelet Medical operates as a pre-revenue B2B medical device business targeting hospitals, academic medical centers, and healthcare systems as its primary customer segment, with a planned enterprise field-sales motion. Its revenue model is hardware sales of the fetal monitoring platform to healthcare providers, though pricing has not been publicly disclosed and no commercial contracts are yet in place. Distribution today is limited to direct pilot partnerships with clinical research sites; commercialization is expected to leverage the Aegis Ventures partnership for global scaling.

Name

Wavelet Medical

Legal name

Wavelet Medical

Website

https://wavelet.co

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

Wavelet Medical is a Yale University spin-out building an AI-powered, non-invasive fetal EEG monitoring platform that uses proprietary machine learning to reconstruct fetal brain activity from abdominal sensors and detect neurological distress in real time for hospital and obstetric care providers.

Ownership category

akta.pro rank

Product category

Fetal Monitoring Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)

akta.pro secondary industries

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE), Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC), Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG), Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG), Maternal-Fetal Medicine (High-Risk Pregnancy/Perinatology) (HLAKAJAB)

Keywords

• Fetal EEG monitoring
• AI medical devices
• Non-invasive brain monitoring
• Obstetric diagnostic equipment
• Fetal neurology analytics

Headquarters

HQ city

New Haven

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel

Revenue model

1. Medical Device Sales: Revenue model not explicitly disclosed in sources. Company appears to be in early-stage pilot phase with clinical validation trials underway, with plans for global commercial expansion through hospital/healthcare system sales.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Wavelet Medical develops and sells a non-invasive fetal electroencephalography (EEG) monitoring platform that uses proprietary AI and machine learning algorithms to reconstruct fetal brain activity from abdominal sensors. The platform detects fetal neurological distress in real time during pregnancy, enabling obstetricians to make timely clinical decisions aimed at preventing brain injuries at birth and reducing unnecessary Caesarean sections. The product is currently being validated in clinical trials at Yale University, LA General Hospital/USC, and Yonsei University Health System.

Product overview

Wavelet Medical offers a single unified product: its AI-powered non-invasive fetal EEG monitoring platform. This platform directly measures fetal brain activity through the mother's abdomen using EEG technology combined with machine learning algorithms to detect neurological distress in real time, addressing the limitations of traditional heart rate monitoring which is indeterminate in up to 85% of births. The platform is currently being piloted at three clinical sites and aims to expand to five to seven U.S. hospitals in urban and rural areas.

Differentiator

Problem solved

Functional benefit

Products and services

• AI Fetal Brain Monitoring Platform A non-invasive fetal EEG monitoring platform that uses proprietary AI algorithms and machine learning to reconstruct and analyze fetal brain activity from abdominal sensors, detecting neurological distress in real time to improve birth outcomes. Designed for hospitals, academic medical centers, and obstetric departments.

Quantifiable outcome

• Traditional heart rate monitoring is indeterminate in up to 85% of births
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Aegis VenturescoreStrategic or Co-development Partner · 14 April 2026Co-creation partnership with Aegis Ventures to accelerate global commercial expansion. Aegis Ventures released whitepaper highlighting Wavelet Medical as a portfolio company demonstrating AI-native medical device capabilities. Partnership includes $7M seed funding and strategic support for scaling the technology globally.
• Yale UniversitycoreStrategic or Co-development Partner · 14 April 2026Technology developed at and spun out from Yale University. Yale serves as a clinical trial site for the non-invasive fetal EEG monitoring platform. Parent institution relationship providing ongoing research collaboration and clinical validation.
• LA General Hospital/USCcoreStrategic or Co-development Partner · 13 April 2026Clinical trial site partner for AI-powered fetal EEG monitoring platform. Conducts clinical validation research alongside academic medical center for technology testing and refinement.
• Yonsei University Health SystemcoreStrategic or Co-development Partner · 13 April 2026International clinical trial site in South Korea for fetal monitoring technology. Part of multi-site clinical validation involving approximately 300 patients across U.S. and international locations.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Natus Medical: Specializes in neurodiagnostic and neonatal monitoring devices, including EEG systems used in clinical settings. Highly comparable to Wavelet's EEG-based neurological monitoring technology stack and hospital GTM motion.
• Compumedics: Manufactures EEG and sleep diagnostic systems with AI-assisted analysis for clinical use. Comparable as a neurology-focused EEG platform vendor targeting hospital and clinical customers.
• BrainScope: Develops AI-powered EEG-based devices for brain injury assessment. Closely comparable to Wavelet in applying machine learning to EEG signals for clinical neurological decision-making.
• Monica Healthcare: Focused on non-invasive fetal monitoring technology for use during labor and pregnancy. Closely comparable to Wavelet's mission of advancing fetal monitoring beyond conventional approaches.
• Neoventa Medical: Specializes in STAN fetal monitoring for assessment of fetal wellbeing during labor. Comparable as a fetal monitoring technology company targeting the same obstetric hospital segment.

Broad incumbents

• Philips Healthcare: Provides the Avalon fetal monitor series alongside a broad portfolio of patient monitoring and connected care solutions. A key incumbent competitor with deep hospital integration and global reach.
• GE Healthcare: A major incumbent offering fetal monitoring products (e.g., Centricity, Corometrics) within a broad portfolio of hospital imaging and monitoring solutions. Represents the dominant installed base Wavelet must displace.
• Edan Instruments: Provides a broad range of patient and fetal monitoring devices globally with growing presence in U.S. hospital channels. Comparable as an incumbent fetal monitoring device competitor.
• Masimo: Diversified patient monitoring company with EEG brain monitoring products (SedLine) alongside its core pulse oximetry franchise. Comparable as an AI-enabled hospital monitoring platform with neurological applications.
• Mindray: Major global medical device company offering fetal and patient monitoring systems across both developed and emerging markets. Represents both a competitor and a potential strategic channel partner for Wavelet.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/wavelet-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wavelet Medical